한글목차

항체 면역조직화학 시장 동향 및 전망

세계 항체 면역조직화학 시장은 2023년부터 2028년까지 4.3%의 CAGR로 2028년까지 약 13억 3,000만 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 단클론 항체에 대한 수요 증가, 신약 개발 연구에서 항체 사용량 증가, 감염 및 암의 면역 조직 화학적 진단 과정에서 항체에 대한 수요 증가입니다. 항체 면역조직화학 시장의 미래는 병원, 진단 연구소 및 학술 기관의 기회로 인해 유망합니다.

항체 면역조직화학 시장 인사이트

• Lucintel의 예측에 따르면, 항체 면역조직화학이 악성종양에 존재하는 비정상 세포의 진단에 상당히 많이 적용되고 있기 때문에 진단 분야가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 진단 실험실 분야는 3제 병용요법을 받은 환자의 생검 샘플에서 헬리코박터 파일로리 진단 정확도를 높이기 위해 항체 면역조직화학이 널리 사용되고 있어 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 북미는 암 및 만성질환 환자 수 증가, 노인 인구 증가, 주요 기업의 존재로 인해 가장 큰 지역이 될 것입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답을 제시합니다:

• Q1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q2. 향후 성장이 가속화될 부문과 그 이유는?
• Q3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q6. 이 시장의 새로운 트렌드와 그 이유는?
• Q7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q9. 이 시장의 주요 기업은? 그리고 주요 기업들은 어떤 전략적인 노력을 기울이고 있는가?
• Q10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤습니까?

목차

제1장 주요 요약

제2장 세계의 항체 면역조직화학 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2017년부터 2028년까지 시장 동향과 예측 분석

• 거시경제 동향(2017-2022년)과 예측(2023-2028년)
• 세계의 항체 면역조직화학 시장 동향(2017-2022) 및 예측(2023-2028)
• 제품 유형별 세계 항체 면역조직화학 시장
  • 단클론항체
  • 다클론항체
• 용도별 세계의 항체 면역조직화학 시장
  • 진단
  • 암
  • 감염성
  • 신장질환
  • 자가면역질환
  • 신경질환
  • 조사
  • 기타
• 최종 용도별 세계 항체 면역조직화학 시장
  • 병원
  • 진단 연구소
  • 학술기관
  • 기타

제4장 2017년부터 2028년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 항체 면역조직화학 시장
• 북미의 항체 면역조직화학 시장
• 유럽의 항체 면역조직화학 시장
• 아시아태평양 항체 면역조직화학 시장
• 기타 지역 항체 면역조직화학 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품 유형별 세계 항체 면역조직화학 시장 성장 기회
  • 용도별 세계의 항체 면역조직화학 시장 성장 기회
  • 최종 용도별 세계 항체 면역조직화학 시장 성장 기회
  • 지역별 세계의 항체 면역조직화학 시장 성장 기회
• 세계의 항체 면역조직화학 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 항체 면역조직화학 시장 능력 확대
  • 세계의 항체 면역조직화학 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Merck
• Bio-Techne
• BD Biosciences
• Thermo Fisher Scientific
• Amoy Diagnostics
• Sino Biological
• ACROBiosystems

영문목차

Antibody Immunohistochemistry Market Trends and Forecast

The future of the antibody immunohistochemistry market looks promising with opportunities in hospitals, diagnostic laboratories, and academic institutes. The global antibody immunohistochemistry market is expected to reach an estimated $1.33 billion by 2028 with a CAGR of 4.3% from 2023 to 2028. The major drivers for this market are growing demand for monoclonal antibodies, increasing usage of antibodies in drug discovery research, and rising need of these antibodies in the immunohistochemistry diagnosis process of infectious diseases and cancer.

A more than 150-page report is developed to help in your business decisions.

Antibody Immunohistochemistry Market by Segment

The study includes trends and forecast for the global antibody immunohistochemistry market by product type, application, end use, and region, as follows:

Antibody Immunohistochemistry Market by Product Type [Shipment Analysis by Value from 2017 to 2028]:

• Monoclonal Antibody
• Polyclonal Antibody

Antibody Immunohistochemistry Market by Application [Shipment Analysis by Value from 2017 to 2028]:

• Diagnostics
• Cancer
• Infectious
• Nephrological Diseases
• Autoimmune Diseases
• Neurological Diseases
• Research
• Others

Antibody Immunohistochemistry Market by End Use [Shipment Analysis by Value from 2017 to 2028]:

• Hospitals
• Diagnostic Laboratories
• Academic Institutes
• Others

Antibody Immunohistochemistry Market by Region [Shipment Analysis by Value from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Antibody Immunohistochemistry Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, antibody immunohistochemistry companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antibody immunohistochemistry companies profiled in this report include:

• Merck
• Bio-Techne
• BD Biosciences
• Thermo Fisher Scientific
• Amoy Diagnostics
• Sino Biological
• ACROBiosystems

Antibody Immunohistochemistry Market Insights

• Lucintel forecast that diagnostic segment is expected to witness the highest growth over the forecast period due to the substantial application of antibody immunohistochemistry in the diagnosis of abnormal cells present in malignant tumors.
• Diagnostic laboratory segment is expected to witness the highest growth over the forecast period due to the extensive use of antibody immunohistochemistry to enhance the diagnostic precision of helicobacter pylori in biopsy samples from patients treated with triple therapy.
• North America will remain the largest region due to the growing number of cancer and chronic disease cases, increasing geriatric population, and presence of key players in the region.

Features of the Antibody Immunohistochemistry Market

• Market Size Estimates: Antibody immunohistochemistry market size estimation in terms of value ($B)
• Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
• Segmentation Analysis: Antibody immunohistochemistry market size by various segments, such as by product type, application, end use, and region
• Regional Analysis: Antibody immunohistochemistry market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different product types, applications, end uses, and regions for the antibody immunohistochemistry market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape for the antibody immunohistochemistry market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q1. What is the antibody immunohistochemistry market size?
• Answer: The global antibody immunohistochemistry market is expected to reach an estimated $1.33 billion by 2028.
• Q2. What is the growth forecast for antibody immunohistochemistry market?
• Answer: The global antibody immunohistochemistry market is expected to grow with a CAGR of 4.3% from 2023 to 2028.
• Q3. What are the major drivers influencing the growth of the antibody immunohistochemistry market?
• Answer: The major drivers for this market are growing demand for monoclonal antibodies, increasing usage of antibodies in drug discovery research, and rising need of these antibodies in the immunohistochemistry diagnosis process of infectious diseases and cancer.
• Q4. What are the major segments for antibody immunohistochemistry market?
• Answer: The future of the antibody immunohistochemistry market looks promising with opportunities in hospitals, diagnostic laboratories, and academic institutes.
• Q5. Who are the key antibody immunohistochemistry companies?
• Answer: Some of the key antibody immunohistochemistry companies are as follows:
  • Merck
  • Bio-Techne
  • BD Biosciences
  • Thermo Fisher Scientific
  • Amoy Diagnostics
  • Sino Biological
  • ACROBiosystems
• Q6. Which antibody immunohistochemistry segment will be the largest in future?
• Answer: Lucintel forecasts that diagnostic segment is expected to witness the highest growth over the forecast period due to the substantial application of antibody immunohistochemistry in the diagnosis of abnormal cells present in malignant tumors.
• Q7. In antibody immunohistochemistry market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region due to the growing number of cancer and chronic disease cases, increasing geriatric population, and presence of key players in the region.
• Q8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global antibody immunohistochemistry market by product type (monoclonal antibody and polyclonal antibody), application (diagnostics, cancer, infectious, nephrological diseases, autoimmune diseases, neurological diseases, research, and others), end use (hospitals, diagnostic laboratories, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Antibody Immunohistochemistry Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Global Antibody Immunohistochemistry Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Antibody Immunohistochemistry Market by Product Type
  • 3.3.1: Monoclonal Antibody
  • 3.3.2: Polyclonal Antibody
• 3.4: Global Antibody Immunohistochemistry Market by Application
  • 3.4.1: Diagnostics
  • 3.4.2: Cancer
  • 3.4.3: Infectious
  • 3.4.4: Nephrological Diseases
  • 3.4.5: Autoimmune Diseases
  • 3.4.6: Neurological Diseases
  • 3.4.7: Research
  • 3.4.8: Others
• 3.5: Global Antibody Immunohistochemistry Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostic Laboratories
  • 3.5.3: Academic Institutes
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Global Antibody Immunohistochemistry Market by Region
• 4.2: North American Antibody Immunohistochemistry Market
  • 4.2.1: North American Antibody Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, and Others
  • 4.2.2: North American Antibody Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
• 4.3: European Antibody Immunohistochemistry Market
  • 4.3.1: European Antibody Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, and Others
  • 4.3.2: European Antibody Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
• 4.4: APAC Antibody Immunohistochemistry Market
  • 4.4.1: APAC Antibody Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, and Others
  • 4.4.2: APAC Antibody Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
• 4.5: ROW Antibody Immunohistochemistry Market
  • 4.5.1: ROW Antibody Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, and Others
  • 4.5.2: ROW Antibody Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Antibody Immunohistochemistry Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Antibody Immunohistochemistry Market by Application
  • 6.1.3: Growth Opportunities for the Global Antibody Immunohistochemistry Market by End Use
  • 6.1.4: Growth Opportunities for the Global Antibody Immunohistochemistry Market by Region
• 6.2: Emerging Trends in the Global Antibody Immunohistochemistry Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Antibody Immunohistochemistry Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antibody Immunohistochemistry Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Merck
• 7.2: Bio-Techne
• 7.3: BD Biosciences
• 7.4: Thermo Fisher Scientific
• 7.5: Amoy Diagnostics
• 7.6: Sino Biological
• 7.7: ACROBiosystems